In a watershed moment for the field, the U.S. Food and Drug Administration yesterday approved the first Alzheimer’s treatment that tackles the underlying disease pathology.

The first drug to treat Alzheimer’s disease in 18 years, which was extensively researched at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, has won approval from the Food and Drug Administration.

Progressives are livid at Sen. Joe Manchin, D-W.V. — once again.

Danica Hays is helping build the teacher of tomorrow at UNLV, and she’s not bashful in saying it’s a community effort.

SpaceX launched thousands of tiny sea creatures to the International Space Station on Thursday, along with a plaque-fighting toothpaste experiment and powerful solar panels.

The nation’s first big convention since the onset of the coronavirus pandemic kicked off this week in Las Vegas. Tourism experts hope the World of Concrete event will spur the city’s casino-based economy.

The Food and Drug Administration (FDA) approved Biogen's aducanumab on June 7, making it the first Alzheimer's medication available in nearly 20 years and the only one that could slow the progression of the disease.

For the first time in nearly 20 years, the FDA approved a drug for the treatment of Alzheimer's disease.